Literature DB >> 19708222

Two purified and characterized phospholipases A2 from Cerastes cerastes venom, that inhibit cancerous cell adhesion and migration.

Raoudha Zouari-Kessentini1, José Luis, Aida Karray, Olfa Kallech-Ziri, Najet Srairi-Abid, Amine Bazaa, Erwann Loret, Sofiane Bezzine, Mohamed El Ayeb, Naziha Marrakchi.   

Abstract

Two non-toxic PLA2s were purified to homogeneity from Cerastes cerastes Tunisian snake venom. The purification process employed gel filtration on Sephadex G-75 followed by C18 reverse phase high-pressure liquid chromatography. These two acidic enzymes, namely CC-PLA2-1 and CC-PLA2-2, have a molecular weight of 13,737.52 and 13,705.63 Da, respectively. These two PLA2 are the first reported glycosylated phospholipases A2 purified from snake venom. The rates of glycosylation are 2.5% and 0.5% (w/w), respectively. Specific activities of 1800 U/mg and 2400 U/mg for CC-PLA2-1 and CC-PLA2-2, respectively, were measured at optimal conditions. CC-PLA2-1 and CC-PLA2-2 strongly inhibited coagulation. They also exhibited a marked dose-dependent inhibitory effect on platelet aggregation induced by ADP and arachidonic acid in platelet-rich plasma. Interestingly, CC-PLA2-1 and CC-PLA2-2 inhibited in a dose-dependent manner adhesion of IGR39 melanoma and HT1080 fibrosarcoma cells to fibrinogen and fibronectin. Furthermore, both CC-PLA2-1 and CC-PLA2-2 abolished HT1080 cell migration towards fibrinogen and fibronectin. This activity is reported for the first time for PLA2 enzymes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19708222     DOI: 10.1016/j.toxicon.2009.01.003

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  16 in total

1.  Isolation, functional characterization and proteomic identification of CC2-PLA₂ from Cerastes cerastes venom: a basic platelet-aggregation-inhibiting factor.

Authors:  Fatah Chérifi; Abdelkader Namane; Fatima Laraba-Djebari
Journal:  Protein J       Date:  2014-02       Impact factor: 2.371

2.  CCSV-MPase, a novel procoagulant metalloproteinase from Cerastes cerastes venom: purification, biochemical characterization and protein identification.

Authors:  Fatah Chérifi; Jean-Claude Rousselle; Abdelkader Namane; Fatima Laraba-Djebari
Journal:  Protein J       Date:  2010-10       Impact factor: 2.371

3.  Therapeutic Outcome of Anti-inflammatory and Antioxidative Medicines on the Dermonecrotic Activity of Cerastes cerastes Venom.

Authors:  Abderrezak Khelfi; Habiba Oussedik-Oumehdi; Fatima Laraba-Djebari
Journal:  Inflammation       Date:  2022-03-05       Impact factor: 4.092

4.  MVL-PLA2, a snake venom phospholipase A2, inhibits angiogenesis through an increase in microtubule dynamics and disorganization of focal adhesions.

Authors:  Amine Bazaa; Eddy Pasquier; Céline Defilles; Ines Limam; Raoudha Kessentini-Zouari; Olfa Kallech-Ziri; Assou El Battari; Diane Braguer; Mohamed El Ayeb; Naziha Marrakchi; José Luis
Journal:  PLoS One       Date:  2010-04-12       Impact factor: 3.240

5.  Purification of a phospholipase A(2) from Daboia russelii siamensis venom with anticancer effects.

Authors:  Suchitra Khunsap; Narumol Pakmanee; Orawan Khow; Lawan Chanhome; Visith Sitprija; Montamas Suntravat; Sara E Lucena; John C Perez; Elda E Sánchez
Journal:  J Venom Res       Date:  2011-10-22

Review 6.  Antitumoral activity of snake venom proteins: new trends in cancer therapy.

Authors:  Leonardo A Calderon; Juliana C Sobrinho; Kayena D Zaqueo; Andrea A de Moura; Amy N Grabner; Maurício V Mazzi; Silvana Marcussi; Auro Nomizo; Carla F C Fernandes; Juliana P Zuliani; Bruna M A Carvalho; Saulo L da Silva; Rodrigo G Stábeli; Andreimar M Soares
Journal:  Biomed Res Int       Date:  2014-02-13       Impact factor: 3.411

7.  Interactions of PLA2-s from Vipera lebetina, Vipera berus berus and Naja naja oxiana venom with platelets, bacterial and cancer cells.

Authors:  Mari Samel; Heiki Vija; Imbi Kurvet; Kai Künnis-Beres; Katrin Trummal; Juhan Subbi; Anne Kahru; Jüri Siigur
Journal:  Toxins (Basel)       Date:  2013-01-24       Impact factor: 4.546

Review 8.  Antitumoral potential of Tunisian snake venoms secreted phospholipases A2.

Authors:  Raoudha Zouari-Kessentini; Najet Srairi-Abid; Amine Bazaa; Mohamed El Ayeb; Jose Luis; Naziha Marrakchi
Journal:  Biomed Res Int       Date:  2013-01-31       Impact factor: 3.411

9.  Isolated biomolecules of pharmacological interest in hemostasis from Cerastes cerastes venom.

Authors:  Fatah Chérifi; Fatima Laraba-Djebari
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2013-05-01

10.  Purification and biochemical characterization of three myotoxins from Bothrops mattogrossensis snake venom with toxicity against Leishmania and tumor cells.

Authors:  Andréa A de Moura; Anderson M Kayano; George A Oliveira; Sulamita S Setúbal; João G Ribeiro; Neuza B Barros; Roberto Nicolete; Laura A Moura; Andre L Fuly; Auro Nomizo; Saulo L da Silva; Carla F C Fernandes; Juliana P Zuliani; Rodrigo G Stábeli; Andreimar M Soares; Leonardo A Calderon
Journal:  Biomed Res Int       Date:  2014-03-03       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.